XXXV TIAFT Annual Meeting | Poster Presentations |
PHENETHYLAMINE MAY CONTRIBUTE TO ADVERSE REACTION TO HALLUCINOGENIC PSILOCYBE MUSHROOM INGESTION
Beck O., Helander A.*, Karlson-Stiber C.**, Stephansson N.
Department of Clinical Pharmacology, Karolinska Institute & Hospital
The use of mushrooms containing the hallucinogenic substance psilocybin for intentional intoxication is relatively common. Occasionally, this results in adverse reactions with typical tachycardia which is not evidently caused by psilocybin. The search for other pharmacologically active substances in Psilocybe semilanceata was initiated by a case of prison inmates being disclosed with taking psilocybin-containing mushrooms. These tested positive in the urine drug screening for the amphetamine class of compounds, indicating the presence of unknown amphetamine-related compound(s). This study was done on mushrooms obtained at site from different localities in Sweden, and in connection with a clinical case. Identity of studied mushrooms as Psilocybe semilanceata was confirmed by macroscopic and microscopic inspection. |
Abstract 083 |